Peter Van der Meer - JoVE Visualize

Showing results (191-200 of 345) with videos related to

Pageof 35

Sort By:

The Lancet. Diabetes & Endocrinology|January 23, 2025

Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.

European Journal of Heart Failure|December 18, 2024

Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.

American Heart Journal|September 1, 2014

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient dataMarieke L Fokkema, Peter van der Meer, Sunil V Rao, et al.

Journal of Cardiac Failure|January 26, 2021

The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart FailureGeorge Markousis-Mavrogenis, Jasper Tromp, Robert J Mentz, et al.

International Journal of Molecular Sciences|November 13, 2021

Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human CardiomyocytesNils Bomer, Mario G Pavez-Giani, Frederik E Deiman, et al.

European Heart Journal. Acute Cardiovascular Care|October 13, 2022

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmiasSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.

Trials|January 23, 2024

Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational ExperimentationElmir Omerovic, Mark Petrie, Björn Redfors, et al.

Circulation. Heart Failure|September 30, 2021

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related CardiomyopathyTim R Eijgenraam, Cornelis J Boogerd, Nienke M Stege, et al.

American Heart Journal|August 25, 2015

Diuretic response in acute heart failure-an analysis from ASCEND-HFJozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.

American Heart Journal|September 17, 2021

Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trialMarie-Sophie Ly de Koning, Paulien van Dorp, Solmaz Assa, et al.

Pageof 35

Showing results (191-200 of 345) with videos related to

Sort By:

Pageof 35

The Lancet. Diabetes & Endocrinology|January 23, 2025

Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trialMelanie J Davies, Peter van der Meer, Subodh Verma, et al.

European Journal of Heart Failure|December 18, 2024

Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trialsAlberto Foà, Maria A Pabon, Eugene Braunwald, et al.

American Heart Journal|September 1, 2014

Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient dataMarieke L Fokkema, Peter van der Meer, Sunil V Rao, et al.

Journal of Cardiac Failure|January 26, 2021

The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart FailureGeorge Markousis-Mavrogenis, Jasper Tromp, Robert J Mentz, et al.

International Journal of Molecular Sciences|November 13, 2021

Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human CardiomyocytesNils Bomer, Mario G Pavez-Giani, Frederik E Deiman, et al.

European Heart Journal. Acute Cardiovascular Care|October 13, 2022

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmiasSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.

Trials|January 23, 2024

Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational ExperimentationElmir Omerovic, Mark Petrie, Björn Redfors, et al.

Circulation. Heart Failure|September 30, 2021

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related CardiomyopathyTim R Eijgenraam, Cornelis J Boogerd, Nienke M Stege, et al.

American Heart Journal|August 25, 2015

Diuretic response in acute heart failure-an analysis from ASCEND-HFJozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.

American Heart Journal|September 17, 2021

Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trialMarie-Sophie Ly de Koning, Paulien van Dorp, Solmaz Assa, et al.

Pageof 35